The Structural Basis of Antibody-Antigen Recognition
暂无分享,去创建一个
[1] G. Edelman,et al. On structural and functional relations between antibodies and proteins of the gamma-system. , 1962, Proceedings of the National Academy of Sciences of the United States of America.
[2] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[3] J. Kehoe,et al. Variable region sequences of five human immunoglobulin heavy chains of the VH3 subgroup: definitive identification of four heavy chain hypervariable regions. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Cohen,et al. Antibody structure , 2006 .
[5] Y. S. Liu,et al. Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain. , 1979, The Journal of biological chemistry.
[6] K. R. Woods,et al. Prediction of protein antigenic determinants from amino acid sequences. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Berzofsky,et al. The antigenic structure of proteins: a reappraisal. , 1984, Annual review of immunology.
[8] Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression. , 1985, Journal of immunology.
[9] W R Taylor,et al. Location of ‘continuous’ antigenic determinants in the protruding regions of proteins. , 1986, The EMBO journal.
[10] G. Rose,et al. Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Poljak,et al. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution , 1986, Science.
[12] P. T. Jones,et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.
[13] A. Lesk,et al. Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.
[14] C. Milstein,et al. Reshaping human antibodies: grafting an antilysozyme activity. , 1988, Science.
[15] J. Blalock,et al. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. , 1988, Science.
[16] P. T. Jones,et al. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli , 1989, Nature.
[17] M Levitt,et al. A humanized antibody that binds to the interleukin 2 receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Lesk,et al. Conformations of immunoglobulin hypervariable regions , 1989, Nature.
[19] R. Perlmutter,et al. Structure and evolution of mammalian VH families. , 1990, International immunology.
[20] C. Chothia,et al. The structure of protein-protein recognition sites. , 1990, The Journal of biological chemistry.
[21] A Tramontano,et al. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. , 1990, Journal of molecular biology.
[22] J Saldanha,et al. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. , 1991, Protein engineering.
[23] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[24] C. Queen,et al. Humanized antibodies for therapy , 1991, Nature.
[25] M Kahn,et al. Design and synthesis of a mimetic from an antibody complementarity-determining region. , 1991, Science.
[26] D. Weiner,et al. Design of bioactive peptides based on antibody hypervariable region structures. Development of conformationally constrained and dimeric peptides with enhanced affinity. , 1991, The Journal of biological chemistry.
[27] M. Berry,et al. Use of antibody fragments in immunoaffinity chromatography. Comparison of FV fragments, VH fragments and paralog peptides. , 1992, Journal of chromatography.
[28] Andrew D. Griffiths,et al. By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling , 1992, Bio/Technology.
[29] L. Presta,et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] V. Garsky,et al. Peptide sequences from the hypervariable regions of two monoclonal anti-idiotypic antibodies against the thyrotropin (TSH) receptor are similar to TSH and inhibit TSH-increased cAMP production in FRTL-5 thyroid cells. , 1992, The Journal of biological chemistry.
[31] S. Pincus,et al. Effect of H chain V region on complement activation by immobilized immune complexes. , 1992, Journal of immunology.
[32] B. Wahrén,et al. A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] N. Greenspan,et al. Role of heavy chain constant domains in antibody-antigen interaction. Apparent specificity differences among streptococcal IgG antibodies expressing identical variable domains. , 1993, Journal of immunology.
[34] R L Stanfield,et al. Major antigen-induced domain rearrangements in an antibody. , 1993, Structure.
[35] E. Lasonder,et al. Interaction of lysozyme with synthetic anti-lysozyme D1.3 antibody fragments studied by affinity chromatography and surface plasmon resonance. , 1994, Journal of chromatography. A.
[36] The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model. , 1994, Journal of molecular biology.
[37] E. Padlan,et al. Anatomy of the antibody molecule. , 1994, Molecular immunology.
[38] Chantal Abergel,et al. Identification of specificity‐determining residues in antibodies , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] T. Clackson,et al. A hot spot of binding energy in a hormone-receptor interface , 1995, Science.
[40] R. Mage,et al. Preferential expansion and survival of B lymphocytes based on VH framework 1 and framework 3 expression: "positive" selection in appendix of normal and VH-mutant rabbits. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Xiang,et al. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops. , 1995, Journal of molecular biology.
[42] R. Poljak,et al. Structural features of the reactions between antibodies and protein antigens , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] M. Buckle,et al. Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies? , 1996, The Journal of clinical investigation.
[45] Andrew J. Martin,et al. Antibody-antigen interactions: contact analysis and binding site topography. , 1996, Journal of molecular biology.
[46] M. Turner,et al. Human constant regions influence the antibody binding characteristics of mouse‐human chimeric IgG subclasses , 1996, Immunology.
[47] C. Borrebaeck,et al. Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. , 1996, Molecular immunology.
[48] L. Presta,et al. Antibody Humanization Using Monovalent Phage Display* , 1997, The Journal of Biological Chemistry.
[49] S. Jones,et al. Analysis of protein-protein interaction sites using surface patches. , 1997, Journal of molecular biology.
[50] A. Lesk,et al. Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.
[51] A. McCoy,et al. Electrostatic complementarity at protein/protein interfaces. , 1997, Journal of molecular biology.
[52] S. Jones,et al. Prediction of protein-protein interaction sites using patch analysis. , 1997, Journal of molecular biology.
[53] R L Brady,et al. VL:VH domain rotations in engineered antibodies: Crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs , 1997, Proteins.
[54] J. Scardina,et al. Peptides Derived from the Complementarity-determining Regions of Anti-Mac-1 Antibodies Block Intercellular Adhesion Molecule-1 Interaction with Mac-1* , 1998, The Journal of Biological Chemistry.
[55] K. Takkinen,et al. Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs. , 1998, Immunotechnology : an international journal of immunological engineering.
[56] S. Shapiro,et al. Cardiolipin binding a light chain from lupus-prone mice. , 1998, Biochemistry.
[57] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database. , 1997, Nucleic acids research.
[58] A. Bogan,et al. Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.
[59] P. Pothier,et al. Prophylactic Administration of a Complementarity-Determining Region Derived from a Neutralizing Monoclonal Antibody Is Effective against Respiratory Syncytial Virus Infection in BALB/c Mice , 1998, Journal of Virology.
[60] B. Sandmaier,et al. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency. , 1998, Biophysical journal.
[61] M Ohlin,et al. Complementarity-determining region (CDR) implantation: a theme of recombination. , 1999, Immunotechnology : an international journal of immunological engineering.
[62] J. Tainer,et al. Unraveling the effect of changes in conformation and compactness at the antibody VL‐VH interface upon antigen binding , 1999, Journal of molecular recognition : JMR.
[63] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..
[64] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[65] Expression, refolding, and ferritin-binding activity of the isolated VL-domain of monoclonal antibody F11. , 2000, Biochemistry. Biokhimiia.
[66] Donald M. O'Rourke,et al. Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo , 2000, Nature Biotechnology.
[67] P. Alzari,et al. Can isotype switch modulate antigen‐binding affinity and influence clonal selection? , 2000, European journal of immunology.
[68] A. Plückthun,et al. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. , 2001, Journal of molecular biology.
[69] M. Holmes,et al. Structural Effects of Framework Mutations on a Humanized Anti-Lysozyme Antibody1 , 2001, The Journal of Immunology.
[70] L Vidarte,et al. Serine 132 is the C3 covalent attachment point on the CH1 domain of human IgG1. , 2001, The Journal of biological chemistry.
[71] Sarah A. Teichmann,et al. Principles of protein-protein interactions , 2002, ECCB.
[72] B. Sutton,et al. Evidence for Involvement of a Hydrophobic Patch in Framework Region 1 of Human V4-34-Encoded Igs in Recognition of the Red Blood Cell I Antigen1 , 2002, The Journal of Immunology.
[73] A. Casadevall,et al. Isotype Can Affect the Fine Specificity of an Antibody for a Polysaccharide Antigen1 , 2002, The Journal of Immunology.
[74] Steven A. Frank,et al. Immunology and Evolution of Infectious Disease , 2002 .
[75] K. Tsumoto,et al. Inhibition of hepatitis C virus NS3 protease by peptides derived from complementarity‐determining regions (CDRs) of the monoclonal antibody 8D4: tolerance of a CDR peptide to conformational changes of a target , 2002, FEBS letters.
[76] J. Janin,et al. Dissecting protein–protein recognition sites , 2002, Proteins.
[77] B. Rost,et al. Analysing six types of protein-protein interfaces. , 2003, Journal of molecular biology.
[78] T. Michaelsen,et al. Binding properties and anti-bacterial activities of V-region identical, human IgG and IgM antibodies, against group B Neisseria meningitidis. , 2003, Biochemical Society transactions.
[79] V. Giudicelli,et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.
[80] L. Cavacini,et al. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. , 2003, AIDS research and human retroviruses.
[81] P. Hudson,et al. Engineered antibodies , 2003, Nature Medicine.
[82] Masayuki Oda,et al. Evidence of allosteric conformational changes in the antibody constant region upon antigen binding. , 2003, International immunology.
[83] Kelvin Hsu,et al. Molecular signatures of anti-nuclear antibodies--contribution of heavy chain framework residues. , 2003, Molecular immunology.
[84] Andrew C. R. Martin,et al. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. , 2003, Journal of molecular biology.
[85] Mayuko Takeda-Shitaka,et al. Interaction between the antigen and antibody is controlled by the constant domains: Normal mode dynamics of the HEL–HyHEL‐10 complex , 2003, Protein science : a publication of the Protein Society.
[86] R. Nussinov,et al. Protein–protein interactions: Structurally conserved residues distinguish between binding sites and exposed protein surfaces , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[87] Vladimir Brusic,et al. Computational methods for prediction of T-cell epitopes--a framework for modelling, testing, and applications. , 2004, Methods.
[88] Mats Ohlin,et al. Length of the antibody heavy chain complementarity determining region 3 as a specificity‐determining factor , 2004, Journal of molecular recognition : JMR.
[89] G. Denardo,et al. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[90] R. Raz,et al. ProMate: a structure based prediction program to identify the location of protein-protein binding sites. , 2004, Journal of molecular biology.
[91] Yan Li,et al. Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design. , 2005, Immunology letters.
[92] D. Flower,et al. Benchmarking B cell epitope prediction: Underperformance of existing methods , 2005, Protein science : a publication of the Protein Society.
[93] A. Casadevall,et al. Variable-Region-Identical Antibodies Differing in Isotype Demonstrate Differences in Fine Specificity and Idiotype1 , 2005, The Journal of Immunology.
[94] Fred Dyda,et al. Water molecules in the antibody-antigen interface of the structure of the Fab HyHEL-5-lysozyme complex at 1.7 A resolution: comparison with results from isothermal titration calorimetry. , 2005, Acta crystallographica. Section D, Biological crystallography.
[95] P. Hudson,et al. Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.
[96] Ruben Abagyan,et al. Statistical analysis and prediction of protein–protein interfaces , 2005, Proteins.
[97] Urmila Kulkarni-Kale,et al. CEP: a conformational epitope prediction server , 2005, Nucleic Acids Res..
[98] I. Roterman,et al. The Indirect Generation of Long‐distance Structural Changes in Antibodies upon their Binding to Antigen , 2006, Chemical biology & drug design.
[99] M. Kojima,et al. The role of interface framework residues in determining antibody VH/VL interaction strength and antigen‐binding affinity , 2006, The FEBS journal.
[100] S. Crotty,et al. Immunity and immunological memory following smallpox vaccination , 2006, Immunological reviews.
[101] Ozlem Keskin,et al. Binding induced conformational changes of proteins correlate with their intrinsic fluctuations: a case study of antibodies , 2007, BMC Structural Biology.
[102] J. Salfeld,et al. Isotype selection in antibody engineering , 2007, Nature Biotechnology.
[103] P. Bourne,et al. Antibody-protein interactions: benchmark datasets and prediction tools evaluation , 2007 .
[104] C. MacKenzie,et al. Isolation and affinity maturation of hapten-specific antibodies. , 2007, Biotechnology advances.
[105] Avner Schlessinger,et al. Towards a consensus on datasets and evaluation metrics for developing B‐cell epitope prediction tools , 2007, Journal of molecular recognition : JMR.
[106] A. Casadevall,et al. The Immunoglobulin Heavy Chain Constant Region Affects Kinetic and Thermodynamic Parameters of Antibody Variable Region Interactions with Antigen* , 2007, Journal of Biological Chemistry.
[107] S. Batra,et al. Engineering antibodies for clinical applications. , 2007, Trends in biotechnology.
[108] Wei Wang,et al. Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.
[109] Wei Li,et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes , 2008, BMC Bioinformatics.
[110] Kouhei Tsumoto,et al. Critical contribution of VH–VL interaction to reshaping of an antibody: The case of humanization of anti‐lysozyme antibody, HyHEL‐10 , 2008, Protein science : a publication of the Protein Society.
[111] Haruki Nakamura,et al. Structural classification of CDR‐H3 revisited: A lesson in antibody modeling , 2008, Proteins.
[112] M. Juliano,et al. Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities , 2008, PloS one.
[113] A. Casadevall,et al. The immunoglobulin constant region contributes to affinity and specificity. , 2008, Trends in immunology.
[114] B. Rost,et al. Automated Identification of Complementarity Determining Regions (CDRs) Reveals Peculiar Characteristics of CDRs and B Cell Epitopes1 , 2008, The Journal of Immunology.
[115] A. Casadevall,et al. Isothermal Titration Calorimetry Reveals Differential Binding Thermodynamics of Variable Region-identical Antibodies Differing in Constant Region for a Univalent Ligand* , 2008, Journal of Biological Chemistry.
[116] Pierre Baldi,et al. PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure , 2008, Bioinform..
[117] A. Stringaro,et al. Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence , 2009, PloS one.
[118] Chi Zhang,et al. Prediction of antigenic epitopes on protein surfaces by consensus scoring , 2009, BMC Bioinformatics.
[119] Xinglong Yu,et al. An introduction to epitope prediction methods and software , 2009, Reviews in medical virology.
[120] Di Wu,et al. SEPPA: a computational server for spatial epitope prediction of protein antigens , 2009, Nucleic Acids Res..
[121] Nimrod D. Rubinstein,et al. A machine-learning approach for predicting B-cell epitopes. , 2009, Molecular immunology.
[122] Itay Mayrose,et al. Epitopia: a web-server for predicting B-cell epitopes , 2009, BMC Bioinformatics.
[123] Janice M Reichert,et al. Development trends for therapeutic antibody fragments , 2009, Nature Biotechnology.
[124] Yanay Ofran. Prediction of Protein Interaction Sites , 2009 .
[125] Jinyan Li,et al. Mining for the antibody-antigen interacting associations that predict the B cell epitopes , 2010, BMC Structural Biology.
[126] Gajendra PS Raghava,et al. Identification of conformational B-cell Epitopes in an antigen from its primary sequence , 2010, Immunome research.
[127] Hiroki Shirai,et al. Use of amino acid composition to predict epitope residues of individual antibodies. , 2010, Protein engineering, design & selection : PEDS.
[128] Di Wu,et al. Evaluation of spatial epitope computational tools based on experimentally-confirmed dataset for protein antigens , 2010 .
[129] Bo Yao,et al. EPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results , 2010, BMC Bioinformatics.
[130] A. Casadevall,et al. Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure. , 2010, Molecular immunology.
[131] S. Pillai,et al. B cells and autoimmunity. , 2011, Current opinion in immunology.
[132] Bjoern Peters,et al. Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource. , 2011, Journal of immunological methods.
[133] Benoit M. Macq,et al. Identification of Relevant Properties for Epitopes Detection Using a Regression Model , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[134] Min-Yuan Chou,et al. Humanization and Characterization of an Anti-Human TNF-α Murine Monoclonal Antibody , 2011, PloS one.
[135] Jinyan Li,et al. Antibody-Specified B-Cell Epitope Prediction in Line with the Principle of Context-Awareness , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[136] Meng Zhao,et al. Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature , 2011, BMC Bioinformatics.
[137] Yanay Ofran,et al. A Systematic Comparison of Free and Bound Antibodies Reveals Binding-Related Conformational Changes , 2012, The Journal of Immunology.
[138] Yanay Ofran,et al. Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure , 2012, Nucleic Acids Res..
[139] M. Zurini,et al. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates. , 2012, Biotechnology journal.
[140] A. Casadevall,et al. Immunoglobulin isotype influences affinity and specificity , 2012, Proceedings of the National Academy of Sciences.
[141] A. Casadevall,et al. The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. , 2012, Journal of autoimmunity.
[142] G. Raghunathan,et al. Antigen‐binding site anatomy and somatic mutations in antibodies that recognize different types of antigens , 2012, Journal of molecular recognition : JMR.
[143] L. Lopalco,et al. Isotype modulates epitope specificity, affinity, and antiviral activities of anti–HIV-1 human broadly neutralizing 2F5 antibody , 2012, Proceedings of the National Academy of Sciences.
[144] J. Haidar,et al. A universal combinatorial design of antibody framework to graft distinct CDR sequences: A bioinformatics approach , 2012, Proteins.
[145] L. Possani,et al. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody. , 2012, Journal of molecular biology.
[146] Yanay Ofran,et al. Structural Consensus among Antibodies Defines the Antigen Binding Site , 2012, PLoS Comput. Biol..
[147] Peter G. Schultz,et al. Reshaping Antibody Diversity , 2013, Cell.
[148] Y. Ofran,et al. The indistinguishability of epitopes from protein surface is explained by the distinct binding preferences of each of the six antigen-binding loops. , 2013, Protein engineering, design & selection : PEDS.
[149] A. Casadevall,et al. The constant region affects antigen binding of antibodies to DNA by altering secondary structure. , 2013, Molecular immunology.
[150] Søren B. Padkjær,et al. Structural analysis of B-cell epitopes in antibody:protein complexes. , 2013, Molecular immunology.
[151] Herman W T van Vlijmen,et al. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework. , 2014, Methods.